Cryoport Inc (CYRX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are mixed, with bearish moving averages and neutral RSI. The financial performance shows revenue growth but significant declines in net income and EPS. Options data suggests low trading sentiment, and there are no recent positive news or catalysts. Given the lack of strong signals and catalysts, holding off on buying is recommended for now.
The MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral at 56.487, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 8.088, with resistance at 8.449 and support at 7.727.

Gross margin improved slightly by 1.57% YoY.
No recent news or significant trading trends from insiders or hedge funds. No recent congress trading data.
In Q4 2025, revenue increased to $45.45M (up 9.64% YoY), but net income dropped to -$13.64M (down 34.01% YoY). EPS declined to -0.27 (down 35.71% YoY), and gross margin improved slightly to 47.77% (up 1.57% YoY).
No recent analyst rating or price target changes available.